Assessing the preclinical progress in the therapeutic targeting of axial spondyloarthritis.
- DOI
- 10.1080/14728222.2026.2722195
- Published
- 2026 Aug
- Container
- Expert opinion on therapeutic targets
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14728222.2026.2722195,
title = {Assessing the preclinical progress in the therapeutic targeting of axial spondyloarthritis.},
author = {Soudy R and Jacoutot M and Gervaise P and Bonini C and Boukamel A and Araujo LM and Costantino F and Glatigny S and Breban M},
year = {2026},
journal = {Expert opinion on therapeutic targets},
doi = {10.1080/14728222.2026.2722195},
url = {https://doi.org/10.1080/14728222.2026.2722195}
}RIS
TY - JOUR TI - Assessing the preclinical progress in the therapeutic targeting of axial spondyloarthritis. AU - Soudy R AU - Jacoutot M AU - Gervaise P AU - Bonini C AU - Boukamel A AU - Araujo LM AU - Costantino F AU - Glatigny S AU - Breban M PY - 2026 JO - Expert opinion on therapeutic targets DO - 10.1080/14728222.2026.2722195 UR - https://doi.org/10.1080/14728222.2026.2722195 ER -
APA
R, S., M, J., P, G., C, B., A, B., LM, A., F, C., S, G., & M, B. (2026). Assessing the preclinical progress in the therapeutic targeting of axial spondyloarthritis.. Expert opinion on therapeutic targets. https://doi.org/10.1080/14728222.2026.2722195
Source records
- pubmed · retrieved 2026-09-26T02:13:20.937Z